Breakfast Symposia

Breakfast Symposium 1

Chairperson: Yeong Sook YOON (Inje University, Korea)
Room 4 / 30 August 2019 (Fri)

07:30-08:30

Fixed ratio co-formulation: which patients can benefit?
Tae Jung OH (Seoul National University, Korea)


Breakfast Symposium 2

Chairperson: Sung Rae KIM (The Catholic University of Korea, Korea)
Room 5 / 30 August 2019 (Fri)

07:30-08:30

Which option is more suitable after the dual therapy for Korean T2DM patients? : ‘add on’ or ‘switch’?
So Hun KIM (Inha University, Korea)


Breakfast Symposium 3

Chairperson: Sang Woo OH (Dongguk University, Korea)
Room 4 / 31 August 2019 (Sat)

07:30-08:30

Therapeutic approach for stable glycemic control in type 2 diabetic patients
Hye-Soon KIM (Keimyung University, Korea)


Breakfast Symposium 4

Chairperson: Jae-Heon KANG (Sungkyunkwan University, Korea)
Room 5 / 31 August 2019 (Sat)

07:30-08:30

Cardiorenal benefit of SGLT2 inhibitors in patients with type 2 diabetes mellitus
Eri Toda KATO (Kyoto University Hospital, Japan)


Breakfast Symposium 5

Chairperson: Cheol-Young PARK (Sungkyunkwan Univesrity, Korea)
Room 6 / 31 August 2019 (Sat)

07:30-08:30

Addressing common challenges in obesity treatment and optimizing long-term patient outcomes with combination phentermine plus topiramate extended release
Santosh T. VARGHESE (VIVUS Inc., USA)